In support of a beneficial effect of FXR agonists in the treatment of kidney diseases, streptozotocin injection in FXR KO caused an accelerated progression of DKD with glomerular foam cell accumulation and mesangial matrix expansion. This evidence concerns the gene NR1H4 and diabetic kidney disease.